Triadyme C cervical disc represents a major development for patients who suffer from degenerative disc disease and the medical professionals who care for them. It is highly differentiated from other discs on the market due to its unique material composition, which gives it superior structural integrity, and its exclusive design, which allows for proper biomechanics.
Key benefits:
- Triadyme-C’s patented Tri-Lobe design provides a mobile axis of rotation that mimics natural kinematic motion and has a self-centering capability, unlike the ball-and-socket design of best-selling devices.
- Extreme durability and smoothness
- The device is made from Orthopedic Diamond™, Dymicron’s proprietary patented grade of polycrystalline diamond, one of the hardest and longest-lasting substances known to man. With extreme durability and a low coefficient of friction, Triadyme-C resists the structural breakdown that can release dangerous wear debris into the body.In addition to offering a durable wear surface that nearly eliminates the chance the implant will wear out, the Orthopedic Diamond material doesn’t impede CT or MRI visualizations of key structures.
- An innovative design that mimics nature
- Triadyme-C also features Dymicron’s proprietary Tri-Lobe articulation mechanism, which seats three spherical lobes within three non-congruent, spherical pockets. The motion of the three lobes within their corresponding pockets generates a smooth and gentle centering force that emulates the naturally constrained motion of the spine.
Such natural motion in a longwearing device, which mimics the original disc to protect surrounding nerves and joints, should substantially reduce the need for subsequent fusions.
Designed to treat single-level cervical disc disease using an anterior approach, Triadyme-C is available in multiple footprints to accommodate patient anatomy.
About Dymicron
Founded in 1997, Dymicron consists of dedicated medical device, material science, clinical, and business professionals with the experience and the manufacturing capabilities to successfully commercialize this game-changing technology. The company’s first product is Triadyme-C™, a cervical total disc replacement (cTDR) device intended to enhance disc replacement surgery outcomes. With its CE mark for Triadyme-C in hand, the company plans to follow its European market introduction with PMA approval and sales in the United States. As Dymicron introduces next-generation devices for other applications in coming years, all of which will utilize the same advanced proprietary material, it expects to emerge as one of the world’s leading orthopedic implant device companies.http://www.dymicron.com